Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

Published Date: 18 Oct 2024

May become "treatment of choice" over brentuximab vedotin for all disease stages

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

novel approach to test the toxicity of cancer drugs.

2.

New target points to combination therapy for thwarting multidrug resistance in cancer treatment

3.

Novel biomarkers may improve diagnosis of gallbladder cancer

4.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

5.

Pancreatic cancer RNA vaccine shows durable T cell immunity


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot